Bengt-Harald Jonsson

Corporate Officer/Principal bei University of Linköping

75 Jahre

Health Technology

Consumer Services

Profil

Bengt-Harald Jonsson is currently a Professor of Molecular Biotechnology at the University of Linköping.
He previously worked as a Director at ModPro AB.

Aktive Positionen von Bengt-Harald Jonsson

Unternehmen	Position	Beginn
University of Linköping University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services.	Corporate Officer/Principal	30.10.2009

Alle aktiven Positionen von Bengt-Harald Jonsson

Ehemalige bekannte Positionen von Bengt-Harald Jonsson

Unternehmen	Position	Ende
ModPro AB ModPro AB Medical SpecialtiesHealth Technology ModPro AB is a holding company that develops novel proprietary concept for recognition and binding of proteins in vitro and in vivo. It is a biopharmaceutical company that designs and produces synthetic binders for proteins for applications in diagnostics, drug development, molecular imaging, and for protein purification. Its technology combines small organic molecules, or "hot spot" mimics with polypeptides from a designed set to form powerful binders for proteins. Its concept is unprecedented and analogous with protein surfaces involved in protein-protein interactions. The company was founded by Lars Harald Baltzer in 2002 and is headquartered in Uppsala, Sweden.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Bengt-Harald Jonsson im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Bengt-Harald Jonsson im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
ModPro AB ModPro AB Medical SpecialtiesHealth Technology ModPro AB is a holding company that develops novel proprietary concept for recognition and binding of proteins in vitro and in vivo. It is a biopharmaceutical company that designs and produces synthetic binders for proteins for applications in diagnostics, drug development, molecular imaging, and for protein purification. Its technology combines small organic molecules, or "hot spot" mimics with polypeptides from a designed set to form powerful binders for proteins. Its concept is unprecedented and analogous with protein surfaces involved in protein-protein interactions. The company was founded by Lars Harald Baltzer in 2002 and is headquartered in Uppsala, Sweden.	Health Technology